In Focus

  • CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and fair and equitable benefit-sharing resulting from access to data.  

    > read the full study

  • G20 Health Ministers recognize the importance of GISAID in regard to data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.
    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).  read more

    > The Berlin Declaration of the G20 Health Ministers

  • GISAID-WHO Bioinformatics Training Workshop
    Madagascar, 22 - 23 March 2018

    During the 6th African Network for the Surveillance of Influenza (ANISE) in Antananarivo, GISAID and isirv - in collaboration with Institut Pasteur de Madagascar and the World Health Organization’s Global Influenza Programme (GIP), with support from USAID - are holding a two-day training workshop on genetic sequence analysis of influenza viruses to provide training for monitoring sequence variation among influenza viruses in relation to surveillance of influenza epidemics and detection of resistance to influenza antiviral drugs.

    > Find out more

  • Data Providers to receive synthetic HA constructs, reverse genetics viruses, and antisera from H5 consortium 

    A consortium of investigators, made up of researchers from the University of Cambridge, the University of Wisconsin at Madison, and the Erasmus Medical Center in Rotterdam makes use of data in GISAID to generate synthetic hemagglutinin constructs to produce recombinant H5 viruses and H5-specific ferret antisera, building antigenic maps to represent all H5 viruses that have circulated from 1997 to the present day, providing critical information to stakeholders around the globe, for example for the design of vaccines for humans or poultry.

    > Find out more

  • Editorial Board affirms Open Access designation of GISAID and DataCite, the world’s leading provider of digital object identifiers (DOI) for research data, affirmed the designation of access to GISAID's database and data as Open Access. A persistent link for this designation has been assigned to GISAID for citation purposes ().  

    GISAID satisfies all conditions of the definition for open access contributions of the Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities, last but not least, due to GISAID's ability "to provide a mechanism to enforce proper attribution“ through its user identification procedures, validating terms of use and licenses.

    > The Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities (2003)

  • GISAID: Global initiative on sharing all influenza data – from vision to reality

    Ten years ago, a correspondence, signed by more than 70 championed ‘A global initiative on sharing avian flu data’, leading to the GISAID Initiative in 2008. What started out as an expression of intent to foster international sharing of all influenza virus data and to publish results collaboratively has emerged as an indispensable mechanism for sharing influenza genetic sequence and metadata that embraces the interests and concerns of the wider influenza community, public health and animal health scientists, along with governments around the world.

    Yuelong Shu et al, Eurosurveillance 22, 13 (30 March 2017) Read more



  • GISAID SAC Informal Consultation on Collaboration with GISRS
    WHO Headquarters, 2 March 2017

    Directors of WHO Collaborating Centers and Members of GISAID's Scientific Advisory Council consulted with the Global Influenza Program, National Influenza Centers and ERLs, as well as industry representatives on the progress of timely virus data sharing through GISAID, followed by round-table discussions.

Sign up for your free Access Credentials

Join & connect with thousands of researchers that made GISAID their primary resource for influenza data

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform and EpiFlu™ database, Singapore and the United States of America